nodes	percent_of_prediction	percent_of_DWPC	metapath
Idarubicin—ABCC1—Methotrexate—esophageal cancer	0.225	0.466	CbGbCtD
Idarubicin—CYP2C9—Capecitabine—esophageal cancer	0.171	0.355	CbGbCtD
Idarubicin—CYP2C9—Cisplatin—esophageal cancer	0.0861	0.179	CbGbCtD
Idarubicin—Palmar-plantar erythrodysaesthesia syndrome—Capecitabine—esophageal cancer	0.0189	0.0552	CcSEcCtD
Idarubicin—Fluid overload—Carboplatin—esophageal cancer	0.0162	0.0473	CcSEcCtD
Idarubicin—Gastrointestinal toxicity—Capecitabine—esophageal cancer	0.0132	0.0388	CcSEcCtD
Idarubicin—Radiation recall reaction (dermatologic)—Capecitabine—esophageal cancer	0.0132	0.0388	CcSEcCtD
Idarubicin—Recall phenomenon—Capecitabine—esophageal cancer	0.0125	0.0367	CcSEcCtD
Idarubicin—Extravasation—Carboplatin—esophageal cancer	0.0115	0.0337	CcSEcCtD
Idarubicin—Gastrointestinal toxicity—Methotrexate—esophageal cancer	0.00986	0.0289	CcSEcCtD
Idarubicin—Myocarditis—Capecitabine—esophageal cancer	0.0089	0.0261	CcSEcCtD
Idarubicin—Phlebitis—Carboplatin—esophageal cancer	0.00847	0.0248	CcSEcCtD
Idarubicin—Septicemia—Methotrexate—esophageal cancer	0.00713	0.0209	CcSEcCtD
Idarubicin—Myelosuppression—Cisplatin—esophageal cancer	0.00629	0.0184	CcSEcCtD
Idarubicin—Leukaemia—Methotrexate—esophageal cancer	0.00601	0.0176	CcSEcCtD
Idarubicin—Sinus tachycardia—Capecitabine—esophageal cancer	0.0054	0.0158	CcSEcCtD
Idarubicin—Febrile neutropenia—Cisplatin—esophageal cancer	0.0049	0.0143	CcSEcCtD
Idarubicin—Fluid overload—Cisplatin—esophageal cancer	0.00474	0.0139	CcSEcCtD
Idarubicin—Lymphoma—Methotrexate—esophageal cancer	0.00463	0.0136	CcSEcCtD
Idarubicin—Cardiomyopathy—Capecitabine—esophageal cancer	0.00425	0.0124	CcSEcCtD
Idarubicin—Mucosal inflammation—Capecitabine—esophageal cancer	0.00393	0.0115	CcSEcCtD
Idarubicin—Necrosis—Cisplatin—esophageal cancer	0.00376	0.011	CcSEcCtD
Idarubicin—Pericarditis—Methotrexate—esophageal cancer	0.00374	0.0109	CcSEcCtD
Idarubicin—Skin hyperpigmentation—Capecitabine—esophageal cancer	0.00365	0.0107	CcSEcCtD
Idarubicin—Febrile neutropenia—Capecitabine—esophageal cancer	0.00361	0.0106	CcSEcCtD
Idarubicin—Infection—Carboplatin—esophageal cancer	0.00356	0.0104	CcSEcCtD
Idarubicin—Embolism—Capecitabine—esophageal cancer	0.00339	0.00991	CcSEcCtD
Idarubicin—Extravasation—Cisplatin—esophageal cancer	0.00338	0.00989	CcSEcCtD
Idarubicin—Daunorubicin—CYP1B1—esophageal cancer	0.00331	0.176	CrCbGaD
Idarubicin—Doxorubicin—NOS3—esophageal cancer	0.00327	0.174	CrCbGaD
Idarubicin—Bone marrow depression—Capecitabine—esophageal cancer	0.00322	0.00942	CcSEcCtD
Idarubicin—Hyperuricaemia—Cisplatin—esophageal cancer	0.00318	0.0093	CcSEcCtD
Idarubicin—Doxorubicin—NOS2—esophageal cancer	0.00316	0.168	CrCbGaD
Idarubicin—Ulcer—Cisplatin—esophageal cancer	0.00312	0.00912	CcSEcCtD
Idarubicin—Blood uric acid increased—Cisplatin—esophageal cancer	0.003	0.00879	CcSEcCtD
Idarubicin—Mucosal inflammation—Methotrexate—esophageal cancer	0.00292	0.00855	CcSEcCtD
Idarubicin—Body temperature increased—Carboplatin—esophageal cancer	0.00284	0.0083	CcSEcCtD
Idarubicin—Skin hyperpigmentation—Methotrexate—esophageal cancer	0.00272	0.00796	CcSEcCtD
Idarubicin—Febrile neutropenia—Methotrexate—esophageal cancer	0.00269	0.00787	CcSEcCtD
Idarubicin—Doxorubicin—CYP1B1—esophageal cancer	0.00269	0.143	CrCbGaD
Idarubicin—Daunorubicin—ABCC2—esophageal cancer	0.00258	0.137	CrCbGaD
Idarubicin—Embolism—Methotrexate—esophageal cancer	0.00252	0.00738	CcSEcCtD
Idarubicin—Phlebitis—Cisplatin—esophageal cancer	0.00248	0.00727	CcSEcCtD
Idarubicin—Bone marrow depression—Methotrexate—esophageal cancer	0.0024	0.00701	CcSEcCtD
Idarubicin—Cardiac failure congestive—Cisplatin—esophageal cancer	0.00236	0.00691	CcSEcCtD
Idarubicin—Burning sensation—Methotrexate—esophageal cancer	0.00233	0.00682	CcSEcCtD
Idarubicin—Ulcer—Capecitabine—esophageal cancer	0.0023	0.00673	CcSEcCtD
Idarubicin—Doxorubicin—ABCC2—esophageal cancer	0.0021	0.111	CrCbGaD
Idarubicin—Colitis—Capecitabine—esophageal cancer	0.00209	0.00611	CcSEcCtD
Idarubicin—Necrosis—Methotrexate—esophageal cancer	0.00206	0.00603	CcSEcCtD
Idarubicin—Dehydration—Cisplatin—esophageal cancer	0.00199	0.00583	CcSEcCtD
Idarubicin—Oesophagitis—Capecitabine—esophageal cancer	0.00199	0.00581	CcSEcCtD
Idarubicin—Neoplasm—Capecitabine—esophageal cancer	0.00197	0.00575	CcSEcCtD
Idarubicin—Sepsis—Capecitabine—esophageal cancer	0.00189	0.00552	CcSEcCtD
Idarubicin—Extravasation—Methotrexate—esophageal cancer	0.00185	0.00543	CcSEcCtD
Idarubicin—Phlebitis—Capecitabine—esophageal cancer	0.00183	0.00536	CcSEcCtD
Idarubicin—Thrombophlebitis—Capecitabine—esophageal cancer	0.00182	0.00533	CcSEcCtD
Idarubicin—Hepatic function abnormal—Capecitabine—esophageal cancer	0.00181	0.00528	CcSEcCtD
Idarubicin—Pancytopenia—Cisplatin—esophageal cancer	0.00176	0.00514	CcSEcCtD
Idarubicin—Hyperuricaemia—Methotrexate—esophageal cancer	0.00174	0.0051	CcSEcCtD
Idarubicin—Ulcer—Methotrexate—esophageal cancer	0.00171	0.00501	CcSEcCtD
Idarubicin—Hot flush—Capecitabine—esophageal cancer	0.00169	0.00494	CcSEcCtD
Idarubicin—Menopausal symptoms—Capecitabine—esophageal cancer	0.00167	0.00489	CcSEcCtD
Idarubicin—Atrial fibrillation—Capecitabine—esophageal cancer	0.00167	0.00487	CcSEcCtD
Idarubicin—Blood uric acid increased—Methotrexate—esophageal cancer	0.00165	0.00482	CcSEcCtD
Idarubicin—Acute coronary syndrome—Cisplatin—esophageal cancer	0.00163	0.00476	CcSEcCtD
Idarubicin—Myocardial infarction—Cisplatin—esophageal cancer	0.00162	0.00473	CcSEcCtD
Idarubicin—Stomatitis—Cisplatin—esophageal cancer	0.00161	0.00471	CcSEcCtD
Idarubicin—Dehydration—Capecitabine—esophageal cancer	0.00147	0.00429	CcSEcCtD
Idarubicin—Neoplasm—Methotrexate—esophageal cancer	0.00146	0.00428	CcSEcCtD
Idarubicin—Urinary tract disorder—Cisplatin—esophageal cancer	0.00146	0.00428	CcSEcCtD
Idarubicin—Urethral disorder—Cisplatin—esophageal cancer	0.00145	0.00425	CcSEcCtD
Idarubicin—Sepsis—Methotrexate—esophageal cancer	0.0014	0.00411	CcSEcCtD
Idarubicin—Flushing—Cisplatin—esophageal cancer	0.00137	0.00402	CcSEcCtD
Idarubicin—Thrombophlebitis—Methotrexate—esophageal cancer	0.00136	0.00397	CcSEcCtD
Idarubicin—Immune system disorder—Cisplatin—esophageal cancer	0.00134	0.00391	CcSEcCtD
Idarubicin—Arrhythmia—Cisplatin—esophageal cancer	0.00132	0.00387	CcSEcCtD
Idarubicin—Alopecia—Cisplatin—esophageal cancer	0.00131	0.00383	CcSEcCtD
Idarubicin—Pancytopenia—Capecitabine—esophageal cancer	0.0013	0.00379	CcSEcCtD
Idarubicin—Malnutrition—Cisplatin—esophageal cancer	0.00129	0.00377	CcSEcCtD
Idarubicin—Neutropenia—Capecitabine—esophageal cancer	0.00128	0.00373	CcSEcCtD
Idarubicin—Acute coronary syndrome—Capecitabine—esophageal cancer	0.0012	0.00351	CcSEcCtD
Idarubicin—Myocardial infarction—Capecitabine—esophageal cancer	0.00119	0.00349	CcSEcCtD
Idarubicin—Anaemia—Cisplatin—esophageal cancer	0.00119	0.00349	CcSEcCtD
Idarubicin—Stomatitis—Capecitabine—esophageal cancer	0.00119	0.00347	CcSEcCtD
Idarubicin—Leukopenia—Cisplatin—esophageal cancer	0.00115	0.00338	CcSEcCtD
Idarubicin—Convulsion—Cisplatin—esophageal cancer	0.00112	0.00327	CcSEcCtD
Idarubicin—Haemoglobin—Capecitabine—esophageal cancer	0.0011	0.00321	CcSEcCtD
Idarubicin—Haemorrhage—Capecitabine—esophageal cancer	0.00109	0.00319	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00109	0.00319	CcSEcCtD
Idarubicin—Urinary tract disorder—Capecitabine—esophageal cancer	0.00108	0.00315	CcSEcCtD
Idarubicin—Urethral disorder—Capecitabine—esophageal cancer	0.00107	0.00313	CcSEcCtD
Idarubicin—Anaphylactic shock—Cisplatin—esophageal cancer	0.00105	0.00308	CcSEcCtD
Idarubicin—Infection—Cisplatin—esophageal cancer	0.00105	0.00306	CcSEcCtD
Idarubicin—Thrombocytopenia—Cisplatin—esophageal cancer	0.00103	0.00301	CcSEcCtD
Idarubicin—Skin disorder—Cisplatin—esophageal cancer	0.00102	0.00299	CcSEcCtD
Idarubicin—Flushing—Capecitabine—esophageal cancer	0.00101	0.00296	CcSEcCtD
Idarubicin—Anorexia—Cisplatin—esophageal cancer	0.001	0.00293	CcSEcCtD
Idarubicin—Angiopathy—Capecitabine—esophageal cancer	0.00099	0.0029	CcSEcCtD
Idarubicin—Immune system disorder—Capecitabine—esophageal cancer	0.000986	0.00289	CcSEcCtD
Idarubicin—Chills—Capecitabine—esophageal cancer	0.00098	0.00287	CcSEcCtD
Idarubicin—Arrhythmia—Capecitabine—esophageal cancer	0.000975	0.00285	CcSEcCtD
Idarubicin—Alopecia—Capecitabine—esophageal cancer	0.000965	0.00282	CcSEcCtD
Idarubicin—Pancytopenia—Methotrexate—esophageal cancer	0.000964	0.00282	CcSEcCtD
Idarubicin—Malnutrition—Capecitabine—esophageal cancer	0.00095	0.00278	CcSEcCtD
Idarubicin—Daunorubicin—ABCB1—esophageal cancer	0.00095	0.0504	CrCbGaD
Idarubicin—Neutropenia—Methotrexate—esophageal cancer	0.000949	0.00278	CcSEcCtD
Idarubicin—Decreased appetite—Cisplatin—esophageal cancer	0.000915	0.00268	CcSEcCtD
Idarubicin—Stomatitis—Methotrexate—esophageal cancer	0.000882	0.00258	CcSEcCtD
Idarubicin—Anaemia—Capecitabine—esophageal cancer	0.000878	0.00257	CcSEcCtD
Idarubicin—Leukopenia—Capecitabine—esophageal cancer	0.000851	0.00249	CcSEcCtD
Idarubicin—Body temperature increased—Cisplatin—esophageal cancer	0.000832	0.00243	CcSEcCtD
Idarubicin—Haemoglobin—Methotrexate—esophageal cancer	0.000817	0.00239	CcSEcCtD
Idarubicin—Haemorrhage—Methotrexate—esophageal cancer	0.000813	0.00238	CcSEcCtD
Idarubicin—Chest pain—Capecitabine—esophageal cancer	0.000809	0.00237	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000803	0.00235	CcSEcCtD
Idarubicin—Urinary tract disorder—Methotrexate—esophageal cancer	0.000803	0.00235	CcSEcCtD
Idarubicin—Urethral disorder—Methotrexate—esophageal cancer	0.000797	0.00233	CcSEcCtD
Idarubicin—Hypersensitivity—Cisplatin—esophageal cancer	0.000775	0.00227	CcSEcCtD
Idarubicin—Doxorubicin—ABCB1—esophageal cancer	0.000771	0.041	CrCbGaD
Idarubicin—Infection—Capecitabine—esophageal cancer	0.000771	0.00225	CcSEcCtD
Idarubicin—Shock—Capecitabine—esophageal cancer	0.000763	0.00223	CcSEcCtD
Idarubicin—Thrombocytopenia—Capecitabine—esophageal cancer	0.000759	0.00222	CcSEcCtD
Idarubicin—Skin disorder—Capecitabine—esophageal cancer	0.000753	0.0022	CcSEcCtD
Idarubicin—Anorexia—Capecitabine—esophageal cancer	0.000739	0.00216	CcSEcCtD
Idarubicin—Angiopathy—Methotrexate—esophageal cancer	0.000737	0.00216	CcSEcCtD
Idarubicin—Immune system disorder—Methotrexate—esophageal cancer	0.000734	0.00215	CcSEcCtD
Idarubicin—Chills—Methotrexate—esophageal cancer	0.000729	0.00213	CcSEcCtD
Idarubicin—Diarrhoea—Cisplatin—esophageal cancer	0.00072	0.00211	CcSEcCtD
Idarubicin—Alopecia—Methotrexate—esophageal cancer	0.000718	0.0021	CcSEcCtD
Idarubicin—Malnutrition—Methotrexate—esophageal cancer	0.000707	0.00207	CcSEcCtD
Idarubicin—Decreased appetite—Capecitabine—esophageal cancer	0.000674	0.00197	CcSEcCtD
Idarubicin—Vomiting—Cisplatin—esophageal cancer	0.000669	0.00196	CcSEcCtD
Idarubicin—Rash—Cisplatin—esophageal cancer	0.000663	0.00194	CcSEcCtD
Idarubicin—Dermatitis—Cisplatin—esophageal cancer	0.000663	0.00194	CcSEcCtD
Idarubicin—Anaemia—Methotrexate—esophageal cancer	0.000654	0.00191	CcSEcCtD
Idarubicin—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000634	0.00186	CcSEcCtD
Idarubicin—Leukopenia—Methotrexate—esophageal cancer	0.000633	0.00185	CcSEcCtD
Idarubicin—Nausea—Cisplatin—esophageal cancer	0.000625	0.00183	CcSEcCtD
Idarubicin—Urticaria—Capecitabine—esophageal cancer	0.000616	0.0018	CcSEcCtD
Idarubicin—Abdominal pain—Capecitabine—esophageal cancer	0.000613	0.00179	CcSEcCtD
Idarubicin—Body temperature increased—Capecitabine—esophageal cancer	0.000613	0.00179	CcSEcCtD
Idarubicin—Convulsion—Methotrexate—esophageal cancer	0.000613	0.00179	CcSEcCtD
Idarubicin—Chest pain—Methotrexate—esophageal cancer	0.000602	0.00176	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000598	0.00175	CcSEcCtD
Idarubicin—Anaphylactic shock—Methotrexate—esophageal cancer	0.000577	0.00169	CcSEcCtD
Idarubicin—Infection—Methotrexate—esophageal cancer	0.000574	0.00168	CcSEcCtD
Idarubicin—Hypersensitivity—Capecitabine—esophageal cancer	0.000571	0.00167	CcSEcCtD
Idarubicin—Thrombocytopenia—Methotrexate—esophageal cancer	0.000565	0.00165	CcSEcCtD
Idarubicin—Skin disorder—Methotrexate—esophageal cancer	0.000561	0.00164	CcSEcCtD
Idarubicin—Anorexia—Methotrexate—esophageal cancer	0.00055	0.00161	CcSEcCtD
Idarubicin—Diarrhoea—Capecitabine—esophageal cancer	0.000531	0.00155	CcSEcCtD
Idarubicin—Decreased appetite—Methotrexate—esophageal cancer	0.000502	0.00147	CcSEcCtD
Idarubicin—Vomiting—Capecitabine—esophageal cancer	0.000493	0.00144	CcSEcCtD
Idarubicin—Rash—Capecitabine—esophageal cancer	0.000489	0.00143	CcSEcCtD
Idarubicin—Dermatitis—Capecitabine—esophageal cancer	0.000489	0.00143	CcSEcCtD
Idarubicin—Headache—Capecitabine—esophageal cancer	0.000486	0.00142	CcSEcCtD
Idarubicin—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000472	0.00138	CcSEcCtD
Idarubicin—Nausea—Capecitabine—esophageal cancer	0.000461	0.00135	CcSEcCtD
Idarubicin—Urticaria—Methotrexate—esophageal cancer	0.000459	0.00134	CcSEcCtD
Idarubicin—Abdominal pain—Methotrexate—esophageal cancer	0.000456	0.00134	CcSEcCtD
Idarubicin—Body temperature increased—Methotrexate—esophageal cancer	0.000456	0.00134	CcSEcCtD
Idarubicin—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000455	0.0029	CbGpPWpGaD
Idarubicin—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000451	0.00287	CbGpPWpGaD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—esophageal cancer	0.000451	0.00286	CbGpPWpGaD
Idarubicin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000449	0.00286	CbGpPWpGaD
Idarubicin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000445	0.00283	CbGpPWpGaD
Idarubicin—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000443	0.00282	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000443	0.00281	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—RB1—esophageal cancer	0.000441	0.0028	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—HIST1H2BM—esophageal cancer	0.000441	0.0028	CbGpPWpGaD
Idarubicin—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000439	0.00279	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—ADH7—esophageal cancer	0.000439	0.00279	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—ADH7—esophageal cancer	0.000436	0.00277	CbGpPWpGaD
Idarubicin—Hypersensitivity—Methotrexate—esophageal cancer	0.000425	0.00124	CcSEcCtD
Idarubicin—ABCC1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000421	0.00268	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000396	0.00252	CbGpPWpGaD
Idarubicin—Diarrhoea—Methotrexate—esophageal cancer	0.000395	0.00116	CcSEcCtD
Idarubicin—TOP2A—Cell Cycle—HIST1H2BM—esophageal cancer	0.000394	0.00251	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—MAD2L1—esophageal cancer	0.000389	0.00248	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—esophageal cancer	0.000388	0.00247	CbGpPWpGaD
Idarubicin—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000387	0.00246	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—ADH1B—esophageal cancer	0.000385	0.00245	CbGpPWpGaD
Idarubicin—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000384	0.00244	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—ADH1B—esophageal cancer	0.000382	0.00243	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000375	0.00238	CbGpPWpGaD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—esophageal cancer	0.000374	0.00237	CbGpPWpGaD
Idarubicin—Vomiting—Methotrexate—esophageal cancer	0.000367	0.00107	CcSEcCtD
Idarubicin—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000364	0.00231	CbGpPWpGaD
Idarubicin—Rash—Methotrexate—esophageal cancer	0.000364	0.00107	CcSEcCtD
Idarubicin—Dermatitis—Methotrexate—esophageal cancer	0.000364	0.00106	CcSEcCtD
Idarubicin—Headache—Methotrexate—esophageal cancer	0.000362	0.00106	CcSEcCtD
Idarubicin—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000361	0.00229	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—NOS2—esophageal cancer	0.000359	0.00228	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—CYP26A1—esophageal cancer	0.000358	0.00228	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000358	0.00227	CbGpPWpGaD
Idarubicin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—esophageal cancer	0.000357	0.00227	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—CYP26A1—esophageal cancer	0.000355	0.00226	CbGpPWpGaD
Idarubicin—CYP2D6—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000353	0.00225	CbGpPWpGaD
Idarubicin—CYP2C9—Metapathway biotransformation—CYP26A1—esophageal cancer	0.00035	0.00223	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—MAD2L1—esophageal cancer	0.000348	0.00221	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000343	0.00218	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000343	0.00218	CbGpPWpGaD
Idarubicin—Nausea—Methotrexate—esophageal cancer	0.000343	0.001	CcSEcCtD
Idarubicin—TOP2A—Cell Cycle, Mitotic—PSME2—esophageal cancer	0.000342	0.00217	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—PSME1—esophageal cancer	0.000342	0.00217	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	0.000337	0.00214	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	0.000336	0.00213	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—GSTO1—esophageal cancer	0.000333	0.00212	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—GSTO1—esophageal cancer	0.00033	0.0021	CbGpPWpGaD
Idarubicin—CYP2D6—Metapathway biotransformation—GSTO1—esophageal cancer	0.000328	0.00209	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—CCND1—esophageal cancer	0.000328	0.00208	CbGpPWpGaD
Idarubicin—CYP2C9—Metapathway biotransformation—GSTO1—esophageal cancer	0.000326	0.00207	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—esophageal cancer	0.000317	0.00202	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—BUB1B—esophageal cancer	0.000311	0.00198	CbGpPWpGaD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—esophageal cancer	0.000307	0.00195	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—PSME1—esophageal cancer	0.000306	0.00194	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—PSME2—esophageal cancer	0.000306	0.00194	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000299	0.0019	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	0.000289	0.00184	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	0.000281	0.00179	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—BUB1B—esophageal cancer	0.000278	0.00177	CbGpPWpGaD
Idarubicin—ABCC1—Disease—SLC52A3—esophageal cancer	0.000277	0.00176	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	0.000275	0.00175	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—ALDH2—esophageal cancer	0.000271	0.00173	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—ALDH2—esophageal cancer	0.000269	0.00171	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CHEK2—esophageal cancer	0.000265	0.00168	CbGpPWpGaD
Idarubicin—ABCC1—Disease—KMT2D—esophageal cancer	0.000264	0.00168	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—MYC—esophageal cancer	0.000263	0.00167	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000261	0.00166	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.00026	0.00165	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—GSTT1—esophageal cancer	0.000258	0.00164	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—GSTT1—esophageal cancer	0.000256	0.00163	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—CYP2A6—esophageal cancer	0.000255	0.00162	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—CYP2A6—esophageal cancer	0.000253	0.00161	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	0.000248	0.00158	CbGpPWpGaD
Idarubicin—CYP2C9—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000247	0.00157	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—PTGS1—esophageal cancer	0.000242	0.00154	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	0.00024	0.00153	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—PTGS1—esophageal cancer	0.00024	0.00152	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000236	0.0015	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—SLC52A3—esophageal cancer	0.000232	0.00147	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—BLVRB—esophageal cancer	0.000232	0.00147	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	0.000229	0.00145	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—EP300—esophageal cancer	0.000219	0.00139	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000207	0.00132	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—CYP1B1—esophageal cancer	0.000206	0.00131	CbGpPWpGaD
Idarubicin—ABCC1—Disease—FKBP1A—esophageal cancer	0.000205	0.0013	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—CYP1B1—esophageal cancer	0.000204	0.0013	CbGpPWpGaD
Idarubicin—CYP2D6—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000203	0.00129	CbGpPWpGaD
Idarubicin—CYP2C9—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000201	0.00128	CbGpPWpGaD
Idarubicin—ABCC1—Disease—DOCK2—esophageal cancer	0.0002	0.00127	CbGpPWpGaD
Idarubicin—ABCC1—Disease—WIF1—esophageal cancer	0.0002	0.00127	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	0.000199	0.00127	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—SLC10A2—esophageal cancer	0.000197	0.00125	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CA1—esophageal cancer	0.000197	0.00125	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000197	0.00125	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	0.000195	0.00124	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—CYP19A1—esophageal cancer	0.000193	0.00123	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—CYP19A1—esophageal cancer	0.000192	0.00122	CbGpPWpGaD
Idarubicin—CYP2D6—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000191	0.00121	CbGpPWpGaD
Idarubicin—CYP2C9—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000189	0.0012	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CSNK1A1—esophageal cancer	0.000185	0.00117	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CA2—esophageal cancer	0.00018	0.00115	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000176	0.00112	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	0.000169	0.00107	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ADH7—esophageal cancer	0.000168	0.00107	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PLCE1—esophageal cancer	0.000168	0.00107	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000166	0.00105	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	0.000164	0.00104	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—RB1—esophageal cancer	0.000162	0.00103	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—TP53—esophageal cancer	0.000157	0.000998	CbGpPWpGaD
Idarubicin—ABCC1—Disease—ELMO1—esophageal cancer	0.000155	0.000986	CbGpPWpGaD
Idarubicin—ABCC1—Disease—GSTO1—esophageal cancer	0.000152	0.000964	CbGpPWpGaD
Idarubicin—ABCC1—Disease—TPI1—esophageal cancer	0.000152	0.000964	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ADH1B—esophageal cancer	0.000147	0.000934	CbGpPWpGaD
Idarubicin—ABCC1—Disease—ALDOB—esophageal cancer	0.000145	0.000924	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—RB1—esophageal cancer	0.000145	0.00092	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000144	0.000914	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CDKN2A—esophageal cancer	0.000142	0.000904	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—TYMP—esophageal cancer	0.00014	0.000893	CbGpPWpGaD
Idarubicin—ABCC1—Disease—HIST1H2BM—esophageal cancer	0.00014	0.00089	CbGpPWpGaD
Idarubicin—ABCC1—Disease—GAPDH—esophageal cancer	0.00014	0.00089	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000138	0.000877	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CYP26A1—esophageal cancer	0.000137	0.000869	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ALOX15—esophageal cancer	0.000133	0.000846	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000133	0.000845	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CDKN2A—esophageal cancer	0.000127	0.000809	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—TPI1—esophageal cancer	0.000127	0.000807	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GSTO1—esophageal cancer	0.000127	0.000807	CbGpPWpGaD
Idarubicin—ABCC1—Disease—XIAP—esophageal cancer	0.000124	0.000786	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ALDOB—esophageal cancer	0.000122	0.000774	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CCND1—esophageal cancer	0.00012	0.000764	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GAPDH—esophageal cancer	0.000117	0.000745	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	0.000116	0.000739	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CRABP1—esophageal cancer	0.000116	0.000738	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000116	0.000737	CbGpPWpGaD
Idarubicin—ABCC1—Disease—B2M—esophageal cancer	0.000115	0.000731	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—EP300—esophageal cancer	0.000111	0.000703	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GNG7—esophageal cancer	0.00011	0.000702	CbGpPWpGaD
Idarubicin—ABCC1—Disease—ENO1—esophageal cancer	0.00011	0.000701	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PSME1—esophageal cancer	0.000109	0.00069	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PSME2—esophageal cancer	0.000109	0.00069	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CCND1—esophageal cancer	0.000107	0.000683	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CALR—esophageal cancer	0.000104	0.000662	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CDKN1A—esophageal cancer	0.000104	0.000661	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—SLC52A3—esophageal cancer	0.000104	0.000661	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—BLVRB—esophageal cancer	0.000104	0.000661	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ALDH2—esophageal cancer	0.000104	0.000658	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—SLC52A3—esophageal cancer	0.000103	0.000655	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—BLVRB—esophageal cancer	0.000103	0.000655	CbGpPWpGaD
Idarubicin—ABCC1—Disease—FBXW7—esophageal cancer	0.000101	0.000641	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—EP300—esophageal cancer	9.89e-05	0.000629	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GSTT1—esophageal cancer	9.85e-05	0.000626	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CYP2A6—esophageal cancer	9.73e-05	0.000619	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	9.7e-05	0.000616	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—MYC—esophageal cancer	9.64e-05	0.000613	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ENO1—esophageal cancer	9.23e-05	0.000587	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PTGS1—esophageal cancer	9.23e-05	0.000587	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	9.22e-05	0.000586	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	9.21e-05	0.000585	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PSME2—esophageal cancer	9.09e-05	0.000578	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PSME1—esophageal cancer	9.09e-05	0.000578	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CA1—esophageal cancer	8.84e-05	0.000562	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—SLC10A2—esophageal cancer	8.84e-05	0.000562	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—SLC10A2—esophageal cancer	8.76e-05	0.000557	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CA1—esophageal cancer	8.76e-05	0.000557	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—MYC—esophageal cancer	8.62e-05	0.000548	CbGpPWpGaD
Idarubicin—ABCC1—Disease—TGFBR2—esophageal cancer	8.15e-05	0.000518	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CA2—esophageal cancer	8.08e-05	0.000514	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CA2—esophageal cancer	8.01e-05	0.000509	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.94e-05	0.000505	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CYP1B1—esophageal cancer	7.85e-05	0.000499	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	7.83e-05	0.000498	CbGpPWpGaD
Idarubicin—ABCC1—Disease—SMAD4—esophageal cancer	7.72e-05	0.000491	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ADH7—esophageal cancer	7.51e-05	0.000478	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PLCE1—esophageal cancer	7.51e-05	0.000478	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PLCE1—esophageal cancer	7.45e-05	0.000474	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ADH7—esophageal cancer	7.45e-05	0.000474	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CYP19A1—esophageal cancer	7.38e-05	0.000469	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	7.36e-05	0.000468	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—TP53—esophageal cancer	7.08e-05	0.00045	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—HMOX1—esophageal cancer	6.73e-05	0.000428	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6.6e-05	0.00042	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ADH1B—esophageal cancer	6.59e-05	0.000419	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ADH1B—esophageal cancer	6.53e-05	0.000415	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ABCB1—esophageal cancer	6.46e-05	0.000411	CbGpPWpGaD
Idarubicin—ABCC1—Disease—HIF1A—esophageal cancer	6.31e-05	0.000401	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—TYMP—esophageal cancer	6.3e-05	0.0004	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—TYMP—esophageal cancer	6.24e-05	0.000397	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CYP26A1—esophageal cancer	6.12e-05	0.000389	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CYP26A1—esophageal cancer	6.07e-05	0.000386	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ALOX15—esophageal cancer	5.97e-05	0.000379	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ALOX15—esophageal cancer	5.92e-05	0.000376	CbGpPWpGaD
Idarubicin—ABCC1—Disease—NOS2—esophageal cancer	5.74e-05	0.000365	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GSTO1—esophageal cancer	5.69e-05	0.000362	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—TPI1—esophageal cancer	5.69e-05	0.000362	CbGpPWpGaD
Idarubicin—ABCC1—Disease—NOTCH1—esophageal cancer	5.69e-05	0.000362	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—TPI1—esophageal cancer	5.64e-05	0.000359	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GSTO1—esophageal cancer	5.64e-05	0.000359	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ALDOB—esophageal cancer	5.46e-05	0.000347	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ALDOB—esophageal cancer	5.41e-05	0.000344	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GAPDH—esophageal cancer	5.25e-05	0.000334	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GAPDH—esophageal cancer	5.21e-05	0.000331	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CRABP1—esophageal cancer	5.21e-05	0.000331	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CRABP1—esophageal cancer	5.16e-05	0.000328	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CREBBP—esophageal cancer	5.16e-05	0.000328	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GNG7—esophageal cancer	4.95e-05	0.000315	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GNG7—esophageal cancer	4.91e-05	0.000312	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.89e-05	0.000311	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ALDH2—esophageal cancer	4.64e-05	0.000295	CbGpPWpGaD
Idarubicin—ABCC1—Disease—NOS3—esophageal cancer	4.62e-05	0.000294	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ALDH2—esophageal cancer	4.6e-05	0.000293	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GSTT1—esophageal cancer	4.42e-05	0.000281	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GSTT1—esophageal cancer	4.38e-05	0.000278	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CYP2A6—esophageal cancer	4.36e-05	0.000277	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CYP2A6—esophageal cancer	4.33e-05	0.000275	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CREBBP—esophageal cancer	4.32e-05	0.000275	CbGpPWpGaD
Idarubicin—ABCC1—Disease—ERBB2—esophageal cancer	4.32e-05	0.000275	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	4.31e-05	0.000274	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PTGS2—esophageal cancer	4.22e-05	0.000268	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PTGS1—esophageal cancer	4.14e-05	0.000263	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ENO1—esophageal cancer	4.14e-05	0.000263	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PTGS1—esophageal cancer	4.1e-05	0.000261	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ENO1—esophageal cancer	4.1e-05	0.000261	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PSME2—esophageal cancer	4.08e-05	0.000259	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PSME1—esophageal cancer	4.08e-05	0.000259	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PSME2—esophageal cancer	4.04e-05	0.000257	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PSME1—esophageal cancer	4.04e-05	0.000257	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—NOS3—esophageal cancer	3.87e-05	0.000246	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CDKN1A—esophageal cancer	3.69e-05	0.000235	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PTGS2—esophageal cancer	3.54e-05	0.000225	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.53e-05	0.000224	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CYP1B1—esophageal cancer	3.52e-05	0.000224	CbGpPWpGaD
Idarubicin—ABCC1—Disease—EP300—esophageal cancer	3.51e-05	0.000223	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CYP1B1—esophageal cancer	3.49e-05	0.000222	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CYP19A1—esophageal cancer	3.31e-05	0.00021	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CYP19A1—esophageal cancer	3.28e-05	0.000208	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MYC—esophageal cancer	3.06e-05	0.000195	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—HMOX1—esophageal cancer	3.02e-05	0.000192	CbGpPWpGaD
Idarubicin—ABCC1—Disease—EGFR—esophageal cancer	2.99e-05	0.00019	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—HMOX1—esophageal cancer	2.99e-05	0.00019	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—EP300—esophageal cancer	2.94e-05	0.000187	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.94e-05	0.000187	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ABCB1—esophageal cancer	2.9e-05	0.000184	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ABCB1—esophageal cancer	2.87e-05	0.000183	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PIK3CA—esophageal cancer	2.6e-05	0.000165	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PIK3CA—esophageal cancer	2.18e-05	0.000138	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.17e-05	0.000138	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CREBBP—esophageal cancer	1.94e-05	0.000123	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CREBBP—esophageal cancer	1.92e-05	0.000122	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—NOS3—esophageal cancer	1.73e-05	0.00011	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—NOS3—esophageal cancer	1.72e-05	0.000109	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PTGS2—esophageal cancer	1.59e-05	0.000101	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PTGS2—esophageal cancer	1.57e-05	9.99e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—EP300—esophageal cancer	1.32e-05	8.38e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—EP300—esophageal cancer	1.31e-05	8.31e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PIK3CA—esophageal cancer	9.75e-06	6.2e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PIK3CA—esophageal cancer	9.67e-06	6.15e-05	CbGpPWpGaD
